These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27976927)

  • 1. Interview with Sanofi's Dr Tunde Falode.
    Falode T
    Future Cardiol; 2017 Jan; 13(1):9-12. PubMed ID: 27976927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interview with Derek Connolly.
    Connolly DL
    Future Cardiol; 2017 Jul; 13(4):327-329. PubMed ID: 28621180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATLANTIC and beyond: an interview with Professor Azfar Zaman.
    Zaman A; Wu W
    Future Cardiol; 2015; 11(1):13-5. PubMed ID: 25606697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interview with Alexander Cohen.
    Cohen AA
    Future Cardiol; 2017 May; 13(3):207-209. PubMed ID: 28569545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Leadership in Paediatric and Congenital Cardiac Care: "Coding our way to improved care: an interview with Rodney C. G. Franklin, MBBS, MD, FRCP, FRCPCH".
    Tretter JT; Jacobs JP
    Cardiol Young; 2021 Jan; 31(1):11-19. PubMed ID: 33526161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alirocumab: A Review in Hypercholesterolemia.
    Greig SL; Deeks ED
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):141-52. PubMed ID: 26935836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interview with Graham Warrellow by Isaac Bruce.
    Warrellow G
    Future Med Chem; 2012 Jun; 4(9):1047-51. PubMed ID: 22709249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding sarcomas and other rare tumors: an interview with Robin L Jones.
    Jones RL
    Future Oncol; 2017 Feb; 13(5):391-394. PubMed ID: 27924638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe hypercholesterolaemia--when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement].
    Cybulska B; Gaciong Z; Hoffman P; Jankowski P; Kłosiewicz-Latoszek L; Kaźmierczak J; Mitręga K; Opolski G; Pająk A; Ponikowski P; Rynkiewicz A; Stępińska J; Średniawa B; Kalarus Z
    Kardiol Pol; 2016; 74(4):394-8. PubMed ID: 27098076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interview: Key questions in pain research: clinical observations informing research and vice versa.
    Bennett D
    Pain Manag; 2011 Mar; 1(2):123-5. PubMed ID: 24646353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A year in the life of a cardiologist: an interview with Dr Ganesh Manoharan. Interview by Louise Rishton (Commissioning Editor) and Tanya Stezhka(Assistant Commissioning Editor).
    Manoharan G
    Expert Rev Cardiovasc Ther; 2013 Apr; 11(4):391-3. PubMed ID: 23570350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two new lipid-regulating drugs.
    Drug Ther Bull; 2016 Feb; 54(2):18-21. PubMed ID: 26868931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alirocumab for the treatment of hypercholesterolaemia.
    Della Pepa G; Bozzetto L; Annuzzi G; Rivellese AA
    Expert Rev Clin Pharmacol; 2017 Jun; 10(6):571-582. PubMed ID: 28395555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarilumab for the treatment of rheumatoid arthritis.
    Cooper S
    Immunotherapy; 2016; 8(3):249-50. PubMed ID: 26860742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interview with Thomas Powles: The use of durvalumab in urothelial cancer - the latest strides in immuno-oncology.
    Powles T
    Future Oncol; 2017 Aug; 13(18):1581-1583. PubMed ID: 28726491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of myocardial infarction in women: are we doing our best? Interviewed by Caroline Telfer.
    Shah A; Telfer C
    Future Cardiol; 2014 Jan; 10(1):31-3. PubMed ID: 24344659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of NuQ nucleosome blood tests for the detection of colon cancer.
    Micallef J; Wilson HL
    Biomark Med; 2014; 8(5):625-7. PubMed ID: 25123030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Potential Role of Alirocumab in the Management of Hypercholesterolemia in Patients with High-Risk Cardiovascular Disease.
    Okere AN; Serra C
    Pharmacotherapy; 2015 Aug; 35(8):771-9. PubMed ID: 26256279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumab.
    Dahagam C; Goud A; Abdelqader A; Hendrani A; Feinstein MJ; Qamar A; Joshi PH; Swiger KJ; Byrne K; Quispe R; Jones SR; Blumenthal RS; Martin SS
    Future Cardiol; 2016 Mar; 12(2):149-57. PubMed ID: 26911710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale.
    Teramoto T; Kondo A; Kiyosue A; Harada-Shiba M; Ishigaki Y; Tobita K; Kawabata Y; Ozaki A; Baccara-Dinet MT; Sata M
    Lipids Health Dis; 2017 Jun; 16(1):121. PubMed ID: 28623954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.